Virus SARS-CoV-2 Envelope Protein Polyclonal antibody, PBS Only

SARS-CoV-2 Envelope Protein Polyclonal Antibody for ELISA, Indirect ELISA

Host / Isotype

Rabbit / IgG

Reactivity

virus

Applications

ELISA, Indirect ELISA

Conjugate

Unconjugated

Cat no : 28904-1-PBS

Synonyms

---

Validation Data Gallery

• 

  ELISA experiment of Recombinant protein using 28904-1-AP (same clone as 28904-1-PBS)

  SARS-CoV-2 Envelope protein Antibody (28904-1-AP) tested by ELISA. SARS-CoV-2 Envelope protein was coated onto microtiter plates at 0.15 µg/well and then incubated with a dilution series of SARS-CoV-2 Envelope protein Antibody (28904-1-AP). Bound antibodies were detected with HRP conjugated anti-Rabbit IgG followed by incubation with HRP Substrate and then measuring the resulting absorbance at 450 nm. This data was developed using the same antibody clone with 28904-1-PBS in a different storage buffer formulation.

---

Product Information

28904-1-PBS targets SARS-CoV-2 Envelope Protein in ELISA, Indirect ELISA applications and shows reactivity with virus samples.

• Tested Reactivity: virus
• Host / Isotype: Rabbit / IgG
• Class: Polyclonal
• Type: Antibody
• Immunogen: SARS-CoV-2 Envelope Protein fusion protein Ag30690
• Full Name: COVID-19 E Protein
• GenBank Accession Number: NC_045512
• Gene Symbol: SARS-CoV-2 Envelope Protein
• Gene ID (NCBI): 43740570
• Conjugate: Unconjugated
• Form: Liquid
• Purification Method: Antigen affinity purification
• Storage Buffer: PBS Only
• Storage Conditions: Store at -80°C.

Background Information

Envelope protein of coronaviruses is a structural protein existing in both monomeric and homopentameric form. It is a minor component of the virus membrane though it is deemed to be important for many stages including virus infection, replication, dissemination and immune response stimulation. Sequence comparison has shown that this protein is identical to the counterparts of specific Bat and Pangolin coronavirus isolates, even though the Sars-CoV-2 sequence seems to possess specific modifications and characteristics with respect to other Sars CoVs(PMID:32596311). The SARS-CoV-2 envelope protein provide a strategy to assess cross-protection against COVID-19 (PMID: 32446902).